biomee ApS
CVR 29829586 · Private limited company (ApS) · Active · Low risk
biomee ApS is a Private limited company (ApS), founded on , based in Hørsholm. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.0% over the next 12 months, which is 0.0 times the average for Danish companies. 19 annual reports have been published, of which 3 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 23.8m and a net result of DKK 6.5m. CEO: Trine Ahlgreen.
Bankruptcy risk for biomee ApS
0.0 × the average (1.41%) · higher risk than 6% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 29829586
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (19 years)
- Address
- c/o MC2 Therapeutics A/S, Agern Alle 24
2970 Hørsholm - Municipality
- Rudersdal
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 1.0m
- Auditor
- Cedra Godkendt Revisionsaktieselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 4 of 19 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 93.2% |
| Current ratio | 1,470% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 2 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 74 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK 4.8m | DKK 4.4m |
| Net profit | DKK 6.5m | DKK 5.5m |
| Equity | DKK 23.8m | DKK 17.2m |
| Total assets | DKK 25.5m | DKK 18.6m |
| Cash | DKK 178k | – |
| Short-term debt | DKK 1.7m | – |
| Avg. employees | 0 | – |
Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · Deloitte Statsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 183 | ||
| 1 Jan 2024 – 31 Dec 2024 | 181 | ||
| 1 Jan 2023 – 31 Dec 2023 | 186 | Late | |
| 1 Jan 2022 – 31 Dec 2022 | 188 | Late | |
| 1 Jan 2021 – 31 Dec 2021 | 181 | ||
| 1 Jan 2020 – 31 Dec 2020 | 182 | ||
| 1 Jan 2019 – 31 Dec 2019 | 227 | Late | |
| 1 Jan 2018 – 31 Dec 2018 | 157 | ||
| 1 Jan 2017 – 31 Dec 2017 | 162 | ||
| 1 Jan 2016 – 31 Dec 2016 | 109 | ||
| 1 Jan 2015 – 31 Dec 2015 | 155 | ||
| 1 Jan 2014 – 31 Dec 2014 | 139 | ||
| 1 Jan 2013 – 31 Dec 2013 | 57 | ||
| 1 Jan 2012 – 31 Dec 2012 | 153 | ||
| 1 Jan 2011 – 31 Dec 2011 | 143 | ||
| 1 Jan 2010 – 31 Dec 2010 | 151 | ||
| 1 Jan 2009 – 31 Dec 2009 | 150 | ||
| 1 Jan 2008 – 31 Dec 2008 | 153 | ||
| 18 Dec 2006 – 31 Dec 2007 | 161 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Trine Ahlgreen | Current | |
| CEO | Jesper Jørn Lange | ||
| Owner (100%) | MC2 Therapeutics A/S | Current | |
| Owner (90%) | MC2 Therapeutics A/S | ||
| Auditor | Cedra Godkendt Revisionsaktieselskab | Current | |
| Auditor | DELOITTE STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Auditor | DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB | ||
| Founder | MC2 Therapeutics A/S | Current | |
| Founder | DRUGMODE ApS | Current |
The CEOs' other companies
Trine Ahlgreen – 2 other companies
- MC2 Therapeutics A/S Active
- ZADEC ApS Active
Jesper Jørn Lange – 13 other companies
- DRUGMODE ApS Fusioneret
- JØRN V. LANGE A/S Opløst
- LANC ApS Active
- LASCH HOLDING ApS Active
- MARIA GRAMS EFTF. ApS Fusioneret
- MC2 BIOACTIVE ApS Fusioneret
- MC2 Therapeutics A/S Active
- PRIDE PROTEOMICS A/S Fusioneret
- TEE CEE HOLDING A/S Opløst
- TOXICELL ApS Opløst
- ViaContext ApS Active
- ZADEC ApS Active
- ZADEC HOLDING ApS Fusioneret
Address history (4 moves)
| c/o MC2 Therapeutics A/S, Agern Alle 24, 2970 Hørsholm | |
| c/o MC2 Biotek ApS, Agern Alle 24, 2970 Hørsholm | |
| c/o MC2 Biotek ApS, Bøge Alle 5, 2970 Hørsholm | |
| c/o MC2 Biotek ApS, Tuborg Havnevej 19, 2900 Hellerup | |
| c/o MC2 Biotek ApS, Tuborg Havnevej 18, 2900 Hellerup |
Former names
| biomee ApS | – now |
| DRUG DELIVERY SOLUTIONS ApS | – |
| TOXICELL ApS | – |
Other companies at the same address
- AVS 07.02.2022 ApS Bankrupt
- Agger Electronic Holding ApS Bankrupt
- Agmondo ApS Bankrupt
- Datoselskabet af 29. august 2024 ApS Bankrupt
- Dinnr ApS Bankrupt
- Euronome Analyzer ApS Bankrupt
- ID2ME A/S Bankrupt
- Kube8 ApS Bankrupt
- SAFESONE HOLDING A/S Bankrupt
- Safesone ApS Bankrupt
- UDVIKLINGSSELSKABET OP2013 ApS Bankrupt
- ACRONORDIC ApS Active
- ALO Patents ApS Active
- ALTOO ApS Active
- Alsted Innovation ApS Active
- Asergo ApS Active
- Asergo Holding ApS Active
- Breye Therapeutics ApS Active
- CLARA INVEST ApS Active
- COLDING CONSULT ApS Active
- CPC - CENTER FOR PRODUCT CUSTOMIZATION ApS Active
- CROXX MED ApS Active
- Central Park Boathouse ApS Active
- Convenience Group ApS Fusioneret
- DALL ENERGY ApS Active
Similar companies in Rudersdal
- Threepoint Therapeutics ApS Hørsholm
- Zaphe ApS Hørsholm
- Floratinia ApS Holte
- Dirac Drives ApS Hørsholm
- Johnsen Bioconsult ApS Skodsborg
- Dantefusion ApS Birkerød
- Typo foods ApS Vedbæk
- Pexinno ApS Holte
- Cerdes Science ApS Birkerød
- Pedersen Scientific ApS Birkerød
- NaviSurg Vision ApS Holte
- Fluispotter ApS Vedbæk
Questions and answers about biomee ApS
Has biomee ApS gone bankrupt?
No, biomee ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of biomee ApS?
Our model estimates a bankruptcy risk of 0.0% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.
Who is the CEO of biomee ApS?
Trine Ahlgreen is the CEO of biomee ApS.
Who is the auditor of biomee ApS?
biomee ApS most recently used Cedra Godkendt Revisionsaktieselskab.
When was biomee ApS founded?
biomee ApS was founded on 18 December 2006.
What is the equity of biomee ApS?
Equity was DKK 23.8m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.